Endothelial activation and injury by cigarette smoke exposure

Journal of Biological Regulators and Homeostatic Agents

Volumn 25, Issue 2, 2011, Pages 259-268

  Guarino, F ^a   Cantarella, G ^a   Caruso, M ^a   Russo, C ^a   Mancuso, S ^a   Arcidiacono, G ^a   Cacciola, R R ^a   Bernardinp, R ^a   Polosa, Ricardo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cigarette smoke extract; Endothelium activation injury; HUVEC; Smoking cessation; Thrombomodulin; Von willebrand factor

Indexed keywords

CIGARETTE SMOKE; LACTATE DEHYDROGENASE; THROMBOMODULIN; VON WILLEBRAND FACTOR;

ARTICLE; CELL ACTIVATION; CELL DAMAGE; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PROTEIN SECRETION; SMOKING CESSATION; UMBILICAL VEIN ENDOTHELIAL CELL; ADULT; BLOOD; CARDIOVASCULAR DISEASE; CELL CULTURE; CHEMISTRY; CROSS-SECTIONAL STUDY; CYTOLOGY; DRUG EFFECT; DRUG MIXTURE; FEMALE; MALE; METABOLISM; PROSPECTIVE STUDY; SMOKING; TOBACCO; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ADULT; CARDIOVASCULAR DISEASES; CELL SURVIVAL; CELLS, CULTURED; COMPLEX MIXTURES; CROSS-SECTIONAL STUDIES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; MALE; PROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; THROMBOMODULIN; TOBACCO; UMBILICAL VEINS; VON WILLEBRAND FACTOR;

EID: 80052889457     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gokce N, Vita JA. Clinical manifestations of endothelial dysfunction. In Thrombosis and Hemorrhage. Loscalzo J, Schafer AI, eds. Lippincott Williams & Wilkins, Philadelphia, PA 2002; 685-706.
2. Landmesser U, Drexler H. Endothelial function and hypertension. Curr Opin Cardiol 2007; 22:316-20. (Pubitemid 46897283)
3. Landmesser U, Hornig B, Drexler H. Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions. Semin Thromb Hemost 2000; 26:529-37.
4. Potenza MA, Gagliardi S, Nacci C, Carratu' MR, Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 2009; 16:94-112.
5. Cacciola RR, Guarino F, Polosa R. Relevance of endothelial-haemostatic dysfunction in cigarette smoking. Curr Med Chem 2007; 14:1887-92. (Pubitemid 47163406)
6. Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis 2003; 46:11-29. (Pubitemid 37013217)
7. Shen Y, Rattan V, Sultana C, Kalra VK. Cigarette smoke condensate-induced adhesion molecule expression and transendothelial migration of monocytes. Am J Physiology 1996; 270:1624-33.
8. Lee SD, Lee DS, Chun YG, Shim TS, Lim CM, Koh Y, Kim WS, Kim DS, Kim WD. Cigarette smoke extract induces endothelin-1 via protein kinase C in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2001; 281:403-11.
9. Bernhard D, Pfister G, Huck CW, Kind M, Salvenmoser W, Bonn GK, Wick G. Disruption of vascular endothelial homeostasis by tobacco smoke: impact on atherosclerosis. FASEB J 2003; 17:2302-04. (Pubitemid 39561473)
10. Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost 2006; 95:49-55.
11. Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood 1990; 76:2024-29.
12. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995; 90:244-48.
13. Markuljak I, Ivankova J, Kubisz P. Thrombomodulin and von Willebrand factor in smokers and during smoking. Nouv Rev Fr Hematol 1995; 37:137-39.
14. Matsushita K, Yamakuchi M, Morrell CN, Ozaki M, O'Rourke B, Irani K, Lowenstein CJ. Vascular endothelial growth factor regulation of Weibel-Palade-body exocytosis. Blood 2005; 105:207-14. (Pubitemid 40053084)
15. Boehme MW, Galle P, Stremmel W. Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals. Immunology 2002; 107:340-49. (Pubitemid 35356954)
16. Halvorsen B, Lund Sagen E, Ueland T, Aukrust P, Tonstad S. Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease. Scand J Clin Lab Invest 2007; 67:604-11. (Pubitemid 351411730)
17. Chen PX, Moldoveanu SC. Mainstream Smoke Chemical Analyses for 2R4F Kentucky Reference Cigarettes. Contribution to Tobacco Research 2003; 20:448-58. (Pubitemid 37470268)
18. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52:2745-56.
19. Vischer UM, Barth H, Wollheim CB. Regulated von Willebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20:883-91. (Pubitemid 30151707)
20. Smoking Cessation. In: U.S. Department of Health and Human Services PHS, Agency for Health Care Policy and Research., ed. Rockville, Md: Government Printing Office; 1996.
21. Piccillo G, Caponnetto P, Barton S, Russo C, Origlio A, Bonaccorsi A, Di Maria A, Oliveri C, Polosa R. Changes in airway hyperresponsiveness following smoking cessation: comparisons between Mch and AMP. Respir Med 2008; 102:256-65. (Pubitemid 350296906)
22. Legrand C, Bour JM, Jacob C, et al. Lactate dehydrogenase (LDH) activity of the cultured eukaryotic cells as marker of the number of dead cells in the medium. J Biotechnol 1992; 25:231-43.
23. Asmussen I, Kjeldsen K. Intimai ultrastructure of human umbilical arteries. Observations on arteries from newborn children of smoking and nonsmoking mothers. Circ Res 1975; 36:579-89.
24. Yu R, Wu M, Lin S, Talbot P. Cigarette smoke toxicants alter growth and survival of cultured mammalian cells. Toxicol Sci 2006; 93:82-95. (Pubitemid 44288252)
25. Yang YM, Liu GT. Damaging effect of cigarette smoke extract on primary cultured human umbilical vein endothelial cells and its mechanism. Biomed Environ Sci 2004; 17:121-34.
26. Blann AD, McCollum CN, Lip GY. Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals. Blood Coagul Fibrinolysis 2002; 13:513-18.
27. Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003; 1:1335-42.
28. Caponnetto P, Russo C, Di Maria A, et al. Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study. Eur J Clin Invest 2010. doi: 10.1111/j.1365-2362.2010. 02449.x. [Epub ahead of print]
29. Johnson HM, Gossett LK, Piper ME, Aeschlimann SE, Korcarz CE, Baker TB, Fiore MC, Stein JH. Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol 2010; 55:1988-95.
30. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88:2149-55. (Pubitemid 23326094)